Results of the sale of scrips. Phase 2 of the offering also successfully completed
26/6/2009
The 550,317 unexercised preferential rights were today, 26 June 2009, offered for sale to institutional investors through an expedited scrip placement procedure at 0.83 euros per scrip. The scrip purchasers subscribed to the 183,439 new shares still available under the same terms and conditions as for Phase 1: one new share for three preferential right scrips at 23.5 euros per share. Now that Phase 2 is completed, the CBFA will be asked to lift the suspension of the WDP share.
